Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis

MLA

Mohsen Mazidi, et al. “Fixed‐dose Combination of Empagliflozin and Linagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta‐analysis.” Diabetes, Obesity and Metabolism, vol. 22, Feb. 2020, pp. 1001–05. EBSCOhost, https://doi.org/10.1111/dom.13989.

APA

Mohsen Mazidi, Richard Ofori-Asenso, Niki Katsiki, & Ele Ferrannini. (2020). Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism, 22, 1001–1005. https://doi.org/10.1111/dom.13989

Chicago

Mohsen Mazidi, Richard Ofori-Asenso, Niki Katsiki, and Ele Ferrannini. 2020. “Fixed‐dose Combination of Empagliflozin and Linagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta‐analysis.” Diabetes, Obesity and Metabolism 22 (February): 1001–5. doi:10.1111/dom.13989.